AcquisitionOther
Servier Pharmaceuticals acquired Day One Biopharmaceuticals
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Servier Pharmaceuticals -> Day One Biopharmaceuticals · $21.50 per share in cash
To acquire portfolio of oncology therapeutics and expand Servier's pipeline.
Open source record (SEC) ↗